CXCL12 and glioblastoma: In this case, the injection of the NPs-CXCL12 may be performed in a second step, the first step being the tumor resection, allowing the access to GBM cells and evaluation of their sensitivity, followed by the implantation of the matrix/wafer adapted to the patient’s requirements to fill the surgical cavity.